|
FDA 关于低价生物类似药和可互换蛋白质产品的声明
2019.12.17
Statement on low-cost biosimilar and interchangeable protein products
For Immediate Release
Statement From
December 17, 2019
Deputy Commissioner for Policy, Legislation, and International Affairs - Food and Drug Administration
Anna Abram
Direct...
|
